On the evening of August 19, Oriental Ocean announced that its wholly-owned subsidiary AiweiKe Biotechnology Co., Ltd. has recently obtained registration approval from the Shandong Provincial Drug Administration for its self-developed interleukin-6 assay kit, receiving a medical device registration certificate. The product is expected to be used for the in vitro quantitative determination of interleukin-6 levels in human serum, plasma, and whole blood
